InsiderClue
Insiders · Profile

Nazzi Gianfranco

EVP, International Markets at TEVA PHARMACEUTICAL INDUSTRIES. Filing since 12 Mar 2018. CIK 0001725018

Company
Date
Role
Action
Shares
Amount
Of holding
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
4 Mar 2021
EVP, International Markets
Sold, plan not stated
12,935
$136.91K
100%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
3 Mar 2021
EVP, International Markets
Sold, plan not stated
1,400
$15.23K
100%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
1 Mar 2021
EVP, International Markets
Sold, plan not stated
75,587
$821.92K
100%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
9 Feb 2021
EVP, International Markets
Sold, plan not stated
21,635
$275.22K
26.4%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
17 Mar 2020
EVP, International Markets
Sold, plan not stated
345
$2.47K
1.7%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
3 Mar 2020
EVP, International Markets
Sold, plan not stated
548
$6.45K
2.8%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
10 Feb 2020
EVP, Growth Markets Commercial
Sold, plan not stated
4,155
$50.86K
18.4%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
18 Sep 2019
EVP, Growth Markets Commercial
Sold, plan not stated
962
$7.52K
8.3%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
18 Mar 2019
EVP, Growth Markets Commercial
Sold, plan not stated
320
$5.33K
3.4%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
12 Mar 2019
EVP, Growth Markets Commercial
Sold, plan not stated
325
$5.10K
3.7%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
4 Mar 2019
EVP, Growth Markets Commercial
Sold, plan not stated
512
$8.64K
6.1%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
18 Sep 2018
EVP, Growth Markets Commercial
Sold, plan not stated
1,379
$32.67K
16.4%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
19 Mar 2018
EVP, Growth Markets Commercial
Sold, plan not stated
457
$8.18K
7.4%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
12 Mar 2018
EVP, Growth Markets Commercial
Sold, plan not stated
461
$8.99K
8.0%
14 decisions on file.